Teva Pharmaceutical Industries Aktie
WKN: 883035 / ISIN: US8816242098
08.05.2024 13:10:49
|
Teva Pharmaceutical Industries Limited Q1 Earnings Summary
(RTTNews) - Below are the earnings highlights for Teva Pharmaceutical Industries Limited (TEVA):
Earnings: -$139 million in Q1 vs. -$220 million in the same period last year. EPS: -$0.12 in Q1 vs. -$0.20 in the same period last year. Excluding items, Teva Pharmaceutical Industries Limited reported adjusted earnings of $548 million or $0.48 per share for the period.
Analysts projected $0.51 per share Revenue: $3.82 billion in Q1 vs. $3.66 billion in the same period last year.
-Guidance: Full year EPS guidance: $2.20 - $2.50 Full year revenue guidance: $15.7 - $16.3 Bln

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Teva Pharmaceutical Industries Ltd. (spons. ADRs)mehr Nachrichten
Analysen zu Teva Pharmaceutical Industries Ltd. (spons. ADRs)mehr Analysen
Aktien in diesem Artikel
Teva Pharmaceutical Industries Ltd. (spons. ADRs) | 15,75 | -3,37% |
|